Dilon to Distribute GE’s Breast Imaging System in Certain Markets

Dilon Diagnostics has reached an agreement to distribute GE Healthcare’s Discovery NM750b molecular breast imaging system in select markets.

The collaboration is an initial step in an ongoing exploration of ways to provide better healthcare solutions for clinicians and their patients, Dilon says.

The system is designed to provide significant enhancement in lesion detectability, including for those with dense breast who may be at higher risk for cancer. — Michael Cipriano